Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 1345982-69-5, Gsk2330672, Gsk-2330672, Iinerixibat, Linerixibat [usan], Chembl2387408
Molecular Formula
C28H38N2O7S
Molecular Weight
546.7  g/mol
InChI Key
CZGVOBIGEBDYTP-VSGBNLITSA-N
FDA UNII
386012Z45S

GSK2330672 has been investigated for the treatment of Diabetes Mellitus, Type 2.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-[[(3R,5R)-3-butyl-3-ethyl-7-methoxy-1,1-dioxo-5-phenyl-4,5-dihydro-2H-16,4-benzothiazepin-8-yl]methylamino]pentanedioic acid
2.1.2 InChI
InChI=1S/C28H38N2O7S/c1-4-6-12-28(5-2)18-38(35,36)24-13-20(17-29-21(14-25(31)32)15-26(33)34)23(37-3)16-22(24)27(30-28)19-10-8-7-9-11-19/h7-11,13,16,21,27,29-30H,4-6,12,14-15,17-18H2,1-3H3,(H,31,32)(H,33,34)/t27-,28-/m1/s1
2.1.3 InChI Key
CZGVOBIGEBDYTP-VSGBNLITSA-N
2.1.4 Canonical SMILES
CCCCC1(CS(=O)(=O)C2=C(C=C(C(=C2)CNC(CC(=O)O)CC(=O)O)OC)C(N1)C3=CC=CC=C3)CC
2.1.5 Isomeric SMILES
CCCC[C@@]1(CS(=O)(=O)C2=C(C=C(C(=C2)CNC(CC(=O)O)CC(=O)O)OC)[C@H](N1)C3=CC=CC=C3)CC
2.2 Other Identifiers
2.2.1 UNII
386012Z45S
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-((((3r,5r)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl)methyl)amino)pentanedioic Acid

2. Gsk2330672

2.3.2 Depositor-Supplied Synonyms

1. 1345982-69-5

2. Gsk2330672

3. Gsk-2330672

4. Iinerixibat

5. Linerixibat [usan]

6. Chembl2387408

7. Linerixibat (usan)

8. 386012z45s

9. 3-[[(3r,5r)-3-butyl-3-ethyl-7-methoxy-1,1-dioxo-5-phenyl-4,5-dihydro-2h-1lambda6,4-benzothiazepin-8-yl]methylamino]pentanedioic Acid

10. Pentanedioic Acid, 3-((((3r,5r)-3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-phenyl-1,4-benzothiazepin-8-yl)methyl)amino)-

11. Unii-386012z45s

12. Pentanedioic Acid, 3-[[[(3r,5r)-3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-phenyl-1,4-benzothiazepin-8-yl]methyl]amino]-

13. Linerixibat [inn]

14. Linerixibat [jan]

15. Linerixibat [who-dd]

16. Schembl2586025

17. Bcp17155

18. Ex-a1180

19. Vdc98269

20. Bdbm50434858

21. Mfcd28386358

22. Who 10729

23. Zinc96270862

24. Cs-5447

25. Db11729

26. Gsk 2330672

27. Ac-36158

28. As-35059

29. Hy-16643

30. D11539

31. Gsk 2330672;gsk-2330672

32. J-690137

33. Q27256749

34. 3-((((3r,5r)-3-butyl-3-ethyl-7-methoxy-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepin-8-yl)methyl)amino)pentanedioic Acid

35. 3-((((3r,5r)-3-butyl-3-ethyl-7-methoxy-1,1-dioxo-5-phenyl-2,3,4,5-tetrahydro- 1h-1.lambda.6,4-benzothiazepin-8-yl)methyl)amino)pentanedioic Acid

36. 3-({[(3r,5r)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioic Acid

37. 3-[[[(3r,5r)-3-bu-3-et-2,3,4,5-tetrahydro-7-ome-1,1-dioxido-5-ph-1,4-benzothiazepin-8-yl]methyl]amino]pentanedioic Acid

38. 3-[[[(3r,5r)-3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-phenyl-1,4-benzothiazepin-8-yl]methyl]amino]pentanedioic Acid

2.4 Create Date
2011-11-21
3 Chemical and Physical Properties
Molecular Weight 546.7 g/mol
Molecular Formula C28H38N2O7S
XLogP3-1.6
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count9
Rotatable Bond Count13
Exact Mass546.23997273 g/mol
Monoisotopic Mass546.23997273 g/mol
Topological Polar Surface Area150 Ų
Heavy Atom Count38
Formal Charge0
Complexity870
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of primary biliary cholangitis